Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2009-08-24EMA Lapsed: Trazec (nateglinide) — Novartis Europharm Ltd.
The EMA page indicates that Trazec (nateglinide) has a lapsed status and is no longer active in the market.
-
CLINICAL_TRIALS trial_result · 2009-08-24Clinical Trial Update: A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male Subjects [Phase 1]
Phase 1 study to characterize the pharmacokinetics and pharmacodynamics and assess the effect of food on DA-1229 in healthy male subjects.
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049) [Phase 3]
This document reports the completion of a Phase 3 comparative trial of sitagliptin in patients with Type 2 diabetes. Results from the study …
-
CLINICAL_TRIALS research · 2009-08-07Clinical Trial Update: Reduce Obesity and Diabetes
A clinical trial update about a study aimed at reducing obesity and diabetes, involving Type 2 Diabetes, pediatric obesity, and dyslipidemia…
-
CLINICAL_TRIALS research · 2009-08-06Clinical Trial Update: Incretin Physiology Associated With Steroid Hormone Treatment [NA]
A completed clinical trial update examining the relationship between incretin physiology and steroid hormone treatment in individuals with T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-08-06Clinical Trial Update: The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients [Phase 4]
Phase 4 clinical trial update evaluating OMACOR (omega-3 fatty acid) on LDL sub-fractions in adults with type 2 diabetes and dyslipidemia.
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes [Phase 4]
Phase 4 trial update from Eli Lilly examining hyperglycemia and cardiovascular outcomes in patients with type 2 diabetes and a history of ac…
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: The Acute Effects of Coffee on Glucose Metabolism [NA]
This clinical trial examined how coffee acutely affects glucose metabolism in people with Type 2 diabetes mellitus, and the study has comple…
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Nurse Telephone Management of Cholesterol in Diabetes [NA]
A completed clinical trial evaluated nurse telephone management of cholesterol in adults with Type 1 diabetes mellitus or Type 2 diabetes me…
-
CLINICAL_TRIALS trial_result · 2009-07-31Clinical Trial Update: Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158) [Phase 4]
A Phase 4 clinical trial assessing the efficacy and safety of sitagliptin in recently diagnosed, treatment-naive type 2 diabetes patients wi…
-
CLINICAL_TRIALS trial_result · 2009-07-31Clinical Trial Update: Single-Dose Study Of PF-04603629 In Type 2 Diabetic Subjects [Phase 1]
A single-dose Phase 1 study of PF-04603629 in adults with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-31Clinical Trial Update: Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes [Phase 4]
A Phase 4 trial examined the effect of exenatide on determinants of glucose homeostasis in type 2 diabetes and has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-31Clinical Trial Update: Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus [Phase 1]
Phase 1 multiple-dose escalation trial of PF-04603629 in subjects with Type 2 diabetes mellitus; the study status is terminated.
-
CLINICAL_TRIALS research · 2009-07-30Clinical Trial Update: Risk Factors of Incidence of Type 2 Diabetes and Cardiovascular Diseases---Shanghai Baoshan Study
An update on the Shanghai Baoshan Study examining risk factors for the development of type 2 diabetes and cardiovascular disease.
-
CLINICAL_TRIALS trial_result · 2009-07-30Clinical Trial Update: Carotid Intima-media Thickness (IMT) and Large-vessel Atherosclerosis by Multidetector Computed Tomography (MDCT)
A completed clinical study evaluating carotid intima-media thickness and large-vessel atherosclerosis using multidetector CT in people with …
-
CLINICAL_TRIALS trial_result · 2009-07-30Clinical Trial Update: Type 2 Diabetes and Exercise - A Pilot Study
Bayside Health's pilot trial evaluating exercise in people with Type 2 diabetes mellitus was terminated.
-
EMA safety_alert · 2009-07-29European Medicines Agency update on safety of insulin glargine - Update
EMA update addressing safety considerations for insulin glargine, summarizing ongoing risk assessments and communications to ensure proper u…
-
CLINICAL_TRIALS trial_result · 2009-07-29Clinical Trial Update: Insulin Dose Titration System Using a Short Messaging Service (SMS) Automatically Produced by a Knowledge Matrix [NA]
Completed clinical trial evaluating an insulin dose titration system that automatically generates SMS-based dosing guidance from a knowledge…
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED) [Phase 1]
Phase 1 completed dose-comparison trial of sitagliptin in adults with Type 2 diabetes mellitus; results posted.
-
CLINICAL_TRIALS trial_result · 2009-07-21Clinical Trial Update: Glycemic Optimization Treatment Study [Phase 4]
Phase 4 trial update on a glycemic optimization treatment for Type 2 diabetes, sponsored by Sanofi. The study status is completed.
-
FDA approval · 2009-07-17FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLOG (insulin aspart) submitted by Novo Nordisk.
-
FDA approval · 2009-07-17FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN 70/30 (human insulin) from Novo Nordisk. The approval updates the labeling/indication fo…
-
FDA approval · 2009-07-17FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) submitted by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2009-07-17Clinical Trial Update: Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin [Phase 4]
This Phase 4 trial reports on beta-cell function when using insulin glargine compared with NPH insulin and with insulin detemir, each in com…
-
CLINICAL_TRIALS trial_result · 2009-07-16Clinical Trial Update: Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP) [Phase 2]
A Phase 2 trial called CLAMP evaluating the effect of DMMET-01 on insulin sensitivity in drug-naive type 2 diabetes patients has completed.